Biosimilars

Latest News

FDA Approves Third Biosimilar of Actemra
FDA Approves Third Biosimilar of Actemra

February 3rd 2025

The new biosimilar, Celltrion’s Avtozma, was approved in both IV and subcutaneous forms to treat inflammatory conditions such as arthritis.

Wezlana, First Stelara Biosimilar To Hit the Market, Available Only Through Optum's Nuvaila
Wezlana, First Stelara Biosimilar To Hit the Market, Available Only Through Optum's Nuvaila

January 22nd 2025

peson on stage | image credit: ©Jezper stock.adobe.com
In This the Year for a Star Turn by Stelara Biosimilars?

January 16th 2025

biosimilars spelled out on blocks | image credit: @lexiconimages stock.adobe.com
Two Prolia Biosimilars, One for Xolair Are in the Offing, Says AscellaHealth Report

January 11th 2025

Javier-stock.adobe.com
Introduction of Biosimilars Led to More Rebates on Humira

December 13th 2024

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.